Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services.
Gaudium IVF and Women Health Limited (GAUDIUMIVF) is listed on the NSE in the Healthcare sector, Medical Care Facilities industry. The GAUDIUMIVF share price is ₹106.44 (+2.17% today), with a market capitalisation of ₹8B and a price-to-earnings (P/E) ratio of 31.5. MarketRipple tracks the GAUDIUMIVF investment thesis, the ripple-chain impact of market events on Gaudium IVF and Women Health Limited, and the Healthcare sector outlook.
Open
₹107.64
High
₹108.94
Low
₹105.43
Prev. Close
₹104.18
52W High
₹163.18
52W Low
₹69.18
Day range
₹105.43–₹108.94
52-week range
₹69.18–₹163.18
Volume
54K
P/E
31.5
ROE
16.1%
D/E
0.16
Margin
21.9%
Gaudium IVF and Women Health Limited (NSE: GAUDIUMIVF) is currently trading at ₹106.44 (+2.17%).
Gaudium IVF and Women Health Limited's market capitalization is ₹8B.
Gaudium IVF and Women Health Limited's price-to-earnings (P/E) ratio is 31.5.
Gaudium IVF and Women Health Limited operates in the Healthcare sector (Medical Care Facilities).